Overall rank by patents
#1,724
of 49,997 tracked assignees
USPTO PatentsView assignee record - 237 granted patents across 88 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12M (Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Ferme).
The verdict
According to USPTO PatentsView, Sartorius ranks #1,724 of 49,997 tracked US assignees by granted-patent volume, with 237 patents across 88 technology areas.
USPTO PatentsView assignee plate
Corpus R1724 · Foreign Corporation #1,724 · 237 grants
GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-DOWN · BOOK-FULL
Nearest grant-volume peer: AVL List GMBH (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
Glaxosmithkline… · near
58 score
I-sens · near
58 score
Perkins Engines · near
58 score
Sartorius Stedim… · this assignee
58 score
V-nova International · near
58 score
3D Lighting… · lowest
7 score
What this shows Sartorius's Innovation Score is 58.3/100 (top 5% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Between 2020–2024, Sartorius Stedim Biotech GmbH received 103 grants versus 118 in 2015–2019 (-13% equal-window velocity, above median growth). Across complete PatentsView years, output peaked in 2019 at 34 grants and bottomed in 2020 at 16. Lead class C12M accounts for 35.4% of the portfolio across 88 subclasses. Volume neighbours: AVL List GMBH (#1,721) and Alps Electric Co., Ltd. (#1,729).
From 2019–2021 to 2022–2024, Sartorius Stedim Biotech GmbH moved from 70 to 67 grants (0.96x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #1,301. See the growth leaderboard.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
AVL List GMBH
237 patents
Faraday & Future Inc.
237 patents
Hitachi Maxell, Ltd.
237 patents
Sicpa Holding SA
237 patents
Tsubakimoto Chain Co.
237 patents
University of Louisville Research Foundation, Inc.
237 patents
Sartorius Stedim Biotech GmbH
237 patents
AAC Microtech (Changzhou) Co., Ltd.
236 patents
Alps Electric Co., Ltd.
236 patents
What this shows Sartorius holds 237 patents at rank #1,725, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #1,725 in granted patent volume.
Other assignees with the most granted patents in Sartorius's primary technology class.
Two PlainPatent-derived peer sets for Sartorius, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (58 here).
Nearest assignees by average claims per patent (13.4 here).
Sartorius's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
58 Top 5% higher than 95% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 25 | 10.5% |
| 2016 | 17 | 7.2% |
| 2017 | 21 | 8.9% |
| 2018 | 21 | 8.9% |
| 2019 | 34 | 14.3% |
| 2020 | 16 | 6.8% |
| 2021 | 20 | 8.4% |
| 2022 | 20 | 8.4% |
| 2023 | 22 | 9.3% |
| 2024 | 25 | 10.5% |
| 2025partial year | 16 | 6.8% |
Top 15 of 88 technology areas
Overall rank by patents
#1,724
of 49,997 tracked assignees
58.3 out of 100
What to do with this data
Sartorius Stedim Biotech GmbH's patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.